4789-81-5 Usage
Uses
Used in Pharmaceutical Synthesis:
Ethyl 2-(quinolin-4-yl)acetate is utilized as a key intermediate in the synthesis of various pharmaceuticals, contributing to the development of new drugs and medicinal agents. Its unique structure allows for the formation of diverse chemical entities with potential therapeutic applications.
Used in Organic Compounds Synthesis:
As a building block, ethyl 2-(quinolin-4-yl)acetate is employed in the synthesis of a wide range of organic compounds, facilitating the creation of complex molecules with specific properties and functions.
Used in Fragrance and Flavoring Applications:
Leveraging its pleasant floral scent, ethyl 2-(quinolin-4-yl)acetate is used as a fragrance ingredient in perfumery, as well as a flavoring agent in the food and beverage industry, enhancing the sensory experience of products.
Used in Heterocyclic Compounds Production:
Ethyl 2-(quinolin-4-yl)acetate serves as a precursor in the production of heterocyclic compounds, which are important in various fields such as pharmaceuticals, agrochemicals, and materials science due to their diverse chemical and biological properties.
In all applications, it is crucial to adhere to proper handling and safety protocols when working with ethyl 2-(quinolin-4-yl)acetate to ensure the well-being of individuals and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 4789-81-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,7,8 and 9 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 4789-81:
(6*4)+(5*7)+(4*8)+(3*9)+(2*8)+(1*1)=135
135 % 10 = 5
So 4789-81-5 is a valid CAS Registry Number.
InChI:InChI=1S/C13H13NO2/c1-2-16-13(15)9-10-7-8-14-12-6-4-3-5-11(10)12/h3-8H,2,9H2,1H3
4789-81-5Relevant academic research and scientific papers
Arylsulfonamide ethers, and methods of use thereof
-
, (2008/06/13)
Novel arylsulfonamide ether compounds and pharmaceutical compositions thereof are described. The use of the novel arylsulfonamide ether compounds and pharmaceutical compositions thereof as inhibitors of interleukin-1β converting enzyme and other cysteine proteases in the ICE family is also decribed. In addition, methods of treating stroke, inflammatory diseases, septic shock, repurfusion injury, Alzheimer's disease, and shigellosis using a compound of the invention or a pharmaceutical composition thereof are described.
Studies on Pyrimidine Derivatives. XXXVIII. Cross-Coupling Reaction of N-Heteroaryl Iodides with Ethoxycarbonylmethylzinc Bromide in the Presence of Palladium Catalyst
Yamanaka, Hiroshi,An-naka, Masayuki,Kondo, Yoshinori,Sakamoto, Takao
, p. 4309 - 4313 (2007/10/02)
In the presence of tetrakis(triphenylphosphine)palladium, 2-iodo-4,6-dimethylpyrimidine and 4-iodo-2,6-dimethylpyrimidine reacted with ethoxycarbonylmethylzinc bromide (Reformatsky reagent) to give ethyl 4,6-dimethyl-2-pyrimidineacetate and ethyl 2,6-dimethyl-4-pyrimidineacetate, respectively.In contrast, the reaction of 5-iodo-2,4-dimethylpyrimidine with the same reagent resulted in recovery of the starting iodide.Similar results were observed in the reactions of various N-heteroaryl iodides.Keywords - Reformatsky reagent; cross-coupling reaction; N-heteroaryl halide; N-heteroarylacetic acid; palladium catalyst; ethyl bromoacetate
